Try our new research platform with insights from 80,000+ expert users
Microsoft Defender for Business Logo

Microsoft Defender for Business Reviews

Vendor: Microsoft
3.9 out of 5

What is Microsoft Defender for Business?

Featured Microsoft Defender for Business reviews

Microsoft Defender for Business mindshare

Product category:
As of April 2025, the mindshare of Microsoft Defender for Business in the Endpoint Protection Platform (EPP) category stands at 1.9%, up from 1.2% compared to the previous year, according to calculations based on PeerSpot user engagement data.
Endpoint Protection Platform (EPP)

PeerResearch reports based on Microsoft Defender for Business reviews

TypeTitleDate
CategoryEndpoint Protection Platform (EPP)Apr 24, 2025Download
ProductReviews, tips, and advice from real usersApr 24, 2025Download
ComparisonMicrosoft Defender for Business vs Microsoft Defender for EndpointApr 24, 2025Download
ComparisonMicrosoft Defender for Business vs CrowdStrike FalconApr 24, 2025Download
ComparisonMicrosoft Defender for Business vs SentinelOne Singularity CompleteApr 24, 2025Download
Suggested products
TitleRatingMindshareRecommending
CrowdStrike Falcon4.311.1%96%126 interviewsAdd to research
Microsoft Defender for Endpoint4.110.9%94%192 interviewsAdd to research
 
 
Key learnings from peers

Valuable Features

Room for Improvement

ROI

Pricing

Popular Use Cases

Service and Support

Deployment

Scalability

Stability

Review data by company size

By reviewers
By visitors reading reviews

Top industries

By visitors reading reviews
Computer Software Company
18%
Comms Service Provider
7%
Retailer
7%
Government
6%
Financial Services Firm
5%
Manufacturing Company
5%
Educational Organization
5%
University
5%
Non Profit
5%
Hospitality Company
4%
Construction Company
4%
Healthcare Company
4%
Insurance Company
3%
Real Estate/Law Firm
3%
Legal Firm
3%
Outsourcing Company
2%
Media Company
2%
Energy/Utilities Company
2%
Wholesaler/Distributor
2%
Performing Arts
1%
Recreational Facilities/Services Company
1%
Transportation Company
1%
Pharma/Biotech Company
1%